Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

PE investment in gastroenterology will likely continue into 2020 — 3 insights

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Strong consolidation activity characterized the physician services sector in the third quarter of 2019, according to Provident Healthcare Partners’ “Q3-2019 Physician Services Update.”

Abe M’Bodj, an Associate at Provident, spoke to Becker’s ASC Review about the recent transactions and what’s on the horizon for the gastroenterology sector.

Note: Responses were lightly edited for style.

Question: What stands out to you about third-quarter activity in the GI sector?

Abe M’Bodj: During the third quarter, there were two highly notable transactions that allowed existing private equity platforms to expand into new states. [Miami-based] Gastro Health’s acquisition of [Seattle-based] Puget Sound Gastroenterology expanded its presence from Florida and Alabama to Washington. This was a big leap for Gastro Health to move to the Pacific Northwest, but it is proving that it’s able to craft unique partnerships around the country. The GI Alliance also made its first large out-of-state acquisition in the third quarter, acquiring [Evanston-based] Illinois Gastroenterology Group. With about 50 doctors, this was a large transaction that provides The GI Alliance with a strong foothold in the Midwest market.

To access the full article click on the following link: PE investment in gastroenterology will likely continue into 2020 — 3 insights

About Becker’s ASC Review
Becker’s ASC Review features general business, legal and clinical guidance on topics relevant to outpatient surgery including joint-ventures, development and expansion, and regulatory and compliance issues; as well as analysis and insight for specialties including bariatrics, orthopedics and spine, gastroenterology, neurosurgery, ophthalmology, ENT and anesthesiology. Each of the nine annual issues of the publication reaches a qualified audience of more than 25,000 key ASC leaders, including surgeons, medical directors, directors of surgery and ASC administrators. Further, every ASC in the nation receives Becker’s ASC Review. Visit Becker’s ASC Review at https://www.beckersasc.com/.